Sanofi/GSK Next-Generation COVID-19 Vaccine Shows Promise As Booster

 
• By Alaric DeArment

Phase III data from two studies of the adjuvanted recombinant vaccine candidate showed increases in neutralizing antibody titers against the original SARS-CoV-2 strain and variants of concern. 

Sanofi/GSK announced booster data for their next-generation COVID-19 vaccine candidate • Source: Shutterstock

More from COVID-19

More from Scrip